抗菌剂
二聚体
抗菌肽
肽
化学
氨基酸
膜透性
细菌
生物膜
多重耐药
生物化学
结构-活动关系
抗生素
膜
体外
生物
有机化学
遗传学
作者
Chao Zhong,Sanhu Gou,Tianqi Liu,Yuewen Zhu,Ningyi Zhu,Hui Liu,Yun Zhang,Junqiu Xie,Xiaomin Guo,Jingman Ni
标识
DOI:10.1016/j.micpath.2019.103871
摘要
Antimicrobial peptides have recently attracted much attention due to their broad-spectrum antimicrobial activity, rapid microbial effects, and minimal tendency toward resistance development. In this study, a series of new C–C terminals and C–N terminals dimer peptides were designed and synthesized by intermolecular dimerization of the partial d-amino acid substitution analogues of Anoplin, and the effects of different dimerization positions on biological activity were researched. The antimicrobial activity and stability of the new C–C terminals and C–N terminals dimer peptides were significantly improved compared with their parent peptide Anoplin. They displayed no obvious hemolytic activity and lower cytotoxicity, with a higher therapeutic index. Furthermore, the new dimer peptides not only enabled to rapidly disrupt bacterial membrane and damage its integrity which was different from conventional antibiotics but also penetrated bacterial membrane into binding to intracellular genomic DNA. More importantly, the new dimer peptides showed excellent antimicrobial activity against multidrug-resistant strains isolated from clinics in contrast to conventional antibiotics with low tendency to develop the bacterial resistance, besides they exhibited better anti-biofilm activity than antibiotic Rifampicin. Interestingly, the C–N terminals dimer peptides were superior to C–C terminals ones in antimicrobial and anti-biofilm activity, therapeutic index, outer membrane permeability, and DNA binding ability, whereas there were no noteworthy effects in different dimerization positions on stability. Thus, these data suggested that dimerization in different positions represented a potent strategy to develop novel antimicrobial agents for fighting against increasing bacterial resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI